| Title | Date | PubMed ID |
|---|
| Gene expression in SK-Mel-28 human melanoma cells treated with the snake venom jararhagin. | 2011 Jan | 20851711 |
| Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. | 2010 Jun 29 | 20614020 |
| Different regions of the class P-III snake venom metalloproteinase jararhagin are involved in binding to alpha2beta1 integrin and collagen. | 2010 Jun 1 | 20056118 |
| Jararhagin, a snake venom metalloprotease-disintegrin, activates the Rac1 GTPase and stimulates neurite outgrowth in neuroblastoma cells. | 2008 Aug 1 | 18653205 |
| Competitive interactions of collagen and a jararhagin-derived disintegrin peptide with the integrin alpha2-I domain. | 2008 Jun 13 | 18417478 |
| Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases. | 2008 Mar | 18096518 |
| BnP1, a novel P-I metalloproteinase from Bothrops neuwiedi venom: biological effects benchmarking relatively to jararhagin, a P-III SVMP. | 2008 Jan | 17889921 |
| Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. | 2007 Jul | 17578514 |
| Mapping von Willebrand factor A domain binding sites on a snake venom metalloproteinase cysteine-rich domain. | 2007 Jan 1 | 17118332 |
| The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting. | 2006 Dec 29 | 17040908 |